FDA sets up new drug safety Web site

Article

The FDA set up a new Web page to provide postmarket drug safety information to patients and providers.

The Food and Drug Administration (FDA) set up a new Web page to provide postmarket drug safety information to patients and providers, American Medical News (11/17/08) reported. The Web site, http://www.fda.gov/cder/drugsafety.htm, was created under the requirements of the FDA Amendments Act of 2007 and enacted last fall to correct drug safety problems.

The site provides links to a variety of information, including drug labeling; medications that have risk evaluation and mitigation strategies; FDA-required postmarket studies and clinical trials of approved products; registry of federally and privately supported clinical trials; and the latest safety information. Included are an index to drug-specific information, drug safety announcements, medical product safety information from MedWatch, and new safety information identified by the Adverse Event Reporting System. Site users also can link to MedWatch, information about warnings and recalls, regulations and guidance documents, general health information, and consumer and professional articles about using medicines safely.

Related Videos
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
raanan meyer, md
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit: uvahealth.com
© 2024 MJH Life Sciences

All rights reserved.